• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位凝胶化后进行局部鸡尾酒化疗免疫疗法,以触发强大的全身抗肿瘤免疫反应。

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.

机构信息

Institute of Functional Nano and Soft Materials (FUNSOM), Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Suzhou, Jiangsu 215123, China.

出版信息

Sci Adv. 2020 Mar 4;6(10):eaaz4204. doi: 10.1126/sciadv.aaz4204. eCollection 2020 Mar.

DOI:10.1126/sciadv.aaz4204
PMID:32181368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7056299/
Abstract

Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here, we report several "cocktail" therapeutic formulations by mixing immunogenic cell death (ICD)-inducing chemotherapeutics and immune adjuvants together with alginate (ALG) for localized chemoimmunotherapy. Immune checkpoint blockade (ICB) antibody may be either included into this cocktail for local injection or used via conventional intravenous injection. After injection of such cocktail into a solid tumor, in-situ gelation of ALG would lead to local retention and sustained release of therapeutics to reduce systemic toxicity. The chemotherapy-induced ICD with the help of immune adjuvant would trigger tumor-specific immune responses, which are further amplified by ICB to elicit potent systemic antitumor immune responses in destructing local tumors, eliminating metastases and inhibiting cancer recurrence. Our strategy of combining clinically used agents for tumor-localized cocktail chemoimmunotherapy possesses great potential for clinical translation.

摘要

目前,人们迫切需要开发具有降低全身毒性和强效疗效的化学免疫疗法,以对抗具有扩散转移的晚期癌症。在这里,我们报告了几种通过将免疫原性细胞死亡(ICD)诱导化疗药物和免疫佐剂与藻酸盐(ALG)混合在一起用于局部化学免疫治疗的“鸡尾酒”治疗制剂。免疫检查点阻断(ICB)抗体可以包含在这种鸡尾酒中进行局部注射,也可以通过常规静脉注射使用。将这种鸡尾酒注入实体瘤后,ALG 的原位凝胶化将导致治疗药物的局部保留和持续释放,以降低全身毒性。在免疫佐剂的帮助下,化疗引起的 ICD 会引发肿瘤特异性免疫反应,这些反应进一步被 ICB 放大,从而引发强烈的全身抗肿瘤免疫反应,破坏局部肿瘤、消除转移和抑制癌症复发。我们将临床使用的药物联合用于肿瘤局部鸡尾酒化学免疫疗法的策略具有很大的临床转化潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/813a58524396/aaz4204-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/02f1e7e9aeaf/aaz4204-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/1933434444f4/aaz4204-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/72cf8dabd7b1/aaz4204-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/ed1d3ba2a716/aaz4204-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/75fb6ca088e8/aaz4204-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/813a58524396/aaz4204-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/02f1e7e9aeaf/aaz4204-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/1933434444f4/aaz4204-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/72cf8dabd7b1/aaz4204-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/ed1d3ba2a716/aaz4204-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/75fb6ca088e8/aaz4204-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4c/7056299/813a58524396/aaz4204-F6.jpg

相似文献

1
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.原位凝胶化后进行局部鸡尾酒化疗免疫疗法,以触发强大的全身抗肿瘤免疫反应。
Sci Adv. 2020 Mar 4;6(10):eaaz4204. doi: 10.1126/sciadv.aaz4204. eCollection 2020 Mar.
2
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.免疫原性细胞死亡通过共定位佐剂传递增强用于癌症免疫治疗。
Nano Lett. 2017 Dec 13;17(12):7387-7393. doi: 10.1021/acs.nanolett.7b03218. Epub 2017 Nov 22.
3
Three steps to breaking immune tolerance to lymphoma: a microparticle approach.打破淋巴瘤免疫耐受的三个步骤:微粒方法。
Cancer Immunol Res. 2015 Apr;3(4):389-98. doi: 10.1158/2326-6066.CIR-14-0173. Epub 2015 Jan 27.
4
IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.白细胞介素-6和程序性死亡配体-1阻断联合治疗可抑制小鼠模型中肝细胞癌的发展。
Biochem Biophys Res Commun. 2017 Apr 29;486(2):239-244. doi: 10.1016/j.bbrc.2017.02.128. Epub 2017 Mar 1.
5
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.通过在可生物降解纳米粒中共同递送阿霉素和免疫佐剂实现有效的化免疫治疗。
Theranostics. 2019 Aug 21;9(22):6485-6500. doi: 10.7150/thno.34429. eCollection 2019.
6
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.免疫检查点阻断与声敏剂增强的无创声动力学治疗联合抑制小鼠肿瘤生长和转移。
Nat Commun. 2019 May 2;10(1):2025. doi: 10.1038/s41467-019-09760-3.
7
PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a Lu-labeled αPD-L1 antibody.正电子发射断层扫描(PET)成像有助于筛选与 Lu 标记的 αPD-L1 抗体协同放射免疫治疗的抗体。
Theranostics. 2021 Jan 1;11(1):304-315. doi: 10.7150/thno.45540. eCollection 2021.
8
Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.通过蛋白相关化学开关生成肿瘤选择性条件激活生物抗 CTLA4 抗体。
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9). doi: 10.1073/pnas.2020606118.
9
ATP-Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity.ATP 响应型智能水凝胶与重复化疗或放疗同步释放免疫佐剂以增强抗肿瘤免疫。
Adv Mater. 2021 May;33(18):e2007910. doi: 10.1002/adma.202007910. Epub 2021 Mar 31.
10
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors.免疫刺激纳米药物与检查点阻断免疫疗法协同作用,以根除结直肠肿瘤。
Nat Commun. 2019 Apr 23;10(1):1899. doi: 10.1038/s41467-019-09221-x.

引用本文的文献

1
Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy.用于联合肿瘤免疫治疗的序贯给药系统的工程策略。
Acta Pharm Sin B. 2025 Aug;15(8):3951-3977. doi: 10.1016/j.apsb.2025.05.039. Epub 2025 Jun 6.
2
Research Strategies and Methods of Hydrogels for Antitumor Drug Delivery.用于抗肿瘤药物递送的水凝胶的研究策略与方法
Biomedicines. 2025 Aug 4;13(8):1899. doi: 10.3390/biomedicines13081899.
3
Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma.

本文引用的文献

1
Hepatocellular Carcinoma Growth Retardation and PD-1 Blockade Therapy Potentiation with Synthetic High-density Lipoprotein.合成高密度脂蛋白抑制肝癌生长和增强 PD-1 阻断治疗效果。
Nano Lett. 2019 Aug 14;19(8):5266-5276. doi: 10.1021/acs.nanolett.9b01717. Epub 2019 Aug 5.
2
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses.联合局部免疫刺激放射性同位素治疗和全身免疫检查点阻断可产生强大的抗肿瘤反应。
Nat Biomed Eng. 2018 Aug;2(8):611-621. doi: 10.1038/s41551-018-0262-6. Epub 2018 Jul 16.
3
Systemic immune effects boost radiotherapy.
基于机器学习构建免疫原性细胞死亡相关评分以改善胶质瘤的预后和个性化治疗
Sci Rep. 2025 Aug 19;15(1):30417. doi: 10.1038/s41598-025-15658-6.
4
Eliciting antitumor immunity via therapeutic cancer vaccines.通过治疗性癌症疫苗激发抗肿瘤免疫力。
Cell Mol Immunol. 2025 Jul 9. doi: 10.1038/s41423-025-01316-4.
5
Engineered in-situ-forming biomimetic hydrogel with self-regulated immunostimulatory capacity promotes postoperative tumor treatment.具有自我调节免疫刺激能力的工程原位形成仿生水凝胶促进术后肿瘤治疗。
Fundam Res. 2023 Jun 2;5(3):1047-1062. doi: 10.1016/j.fmre.2023.02.029. eCollection 2025 May.
6
Progress of Immune-Inducible Biomaterials for Post-Ablation Cancers.免疫诱导生物材料用于消融后癌症的研究进展
Adv Healthc Mater. 2025 Aug;14(21):e2500785. doi: 10.1002/adhm.202500785. Epub 2025 Jun 9.
7
Research prospects and AI-driven strategies for metal-organic framework-hydrogel composite materials in cancer treatment.金属有机框架-水凝胶复合材料在癌症治疗中的研究前景及人工智能驱动策略
RSC Med Chem. 2025 May 1. doi: 10.1039/d5md00207a.
8
Targeting the glioblastoma resection margin with locoregional nanotechnologies.利用局部纳米技术靶向胶质母细胞瘤切除边缘。
Nat Rev Clin Oncol. 2025 May 14. doi: 10.1038/s41571-025-01020-2.
9
Nanotechnology in the perioperative treatment of head and neck cancer: application and outlook.纳米技术在头颈癌围手术期治疗中的应用与展望
Front Bioeng Biotechnol. 2025 Mar 27;13:1566522. doi: 10.3389/fbioe.2025.1566522. eCollection 2025.
10
A syringeable immunotherapeutic hydrogel enhances T cell immunity via activation of STING pathway for advanced breast cancer postoperative therapy.一种可注射的免疫治疗水凝胶通过激活STING通路增强T细胞免疫,用于晚期乳腺癌术后治疗。
Front Immunol. 2025 Mar 19;16:1523436. doi: 10.3389/fimmu.2025.1523436. eCollection 2025.
全身免疫效应增强放射治疗。
Nat Biomed Eng. 2018 Aug;2(8):562-563. doi: 10.1038/s41551-018-0264-4.
4
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.纳米颗粒增强放疗引发强大的癌症免疫治疗。
Adv Mater. 2019 Mar;31(10):e1802228. doi: 10.1002/adma.201802228. Epub 2019 Jan 21.
5
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment.原位喷涂生物响应免疫治疗凝胶用于术后癌症治疗。
Nat Nanotechnol. 2019 Jan;14(1):89-97. doi: 10.1038/s41565-018-0319-4. Epub 2018 Dec 10.
6
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.使用定制的伊立替康递药硅质体治疗原位结肠癌可提高疗效、降低毒性。
ACS Nano. 2019 Jan 22;13(1):38-53. doi: 10.1021/acsnano.8b06164. Epub 2018 Dec 11.
7
Immunomodulating Nanomedicine for Cancer Therapy.免疫调节纳米医学用于癌症治疗。
Nano Lett. 2018 Nov 14;18(11):6655-6659. doi: 10.1021/acs.nanolett.8b02340. Epub 2018 Sep 10.
8
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade.可注射生物响应性凝胶库增强免疫检查点阻断。
Adv Mater. 2018 Jul;30(28):e1801527. doi: 10.1002/adma.201801527. Epub 2018 May 22.
9
DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment.载有阿霉素/白细胞介素-2/干扰素-γ的热敏多肽水凝胶用于高效治疗黑色素瘤。
Bioact Mater. 2017 Sep 6;3(1):118-128. doi: 10.1016/j.bioactmat.2017.08.003. eCollection 2018 Mar.
10
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy.原位形成的活性氧响应支架,联合吉西他滨和检查点抑制剂的用于联合治疗。
Sci Transl Med. 2018 Feb 21;10(429). doi: 10.1126/scitranslmed.aan3682.